Replies to post #424230 on Amarin Corp Plc (AMRN)

[rosemountbomber]

JRoon, Zip, a question about China. A couple of days ago I believe Tats posted a link that described where Epadel was going to be marketed in China. There was a paywall and I also could not find more info about it elsewhere. My question is whether Epadel already has reimbursement, or is just an over the counter there? Would it be competition for V?

[couldbebetter]

JRoon71, What I would like to know is this. Are there any Eurocentric BP that believe they
could get Vazkepa reimbursements from Germany, Italy, & France. For example, if Bayer
owned AMRN would they have the gravitas to get reimbursements for Germany? If so, why
wouldn't one of these make their move? Then there is the question of Vazkepa being studied
as an adjunct drug for use with any other cancer therapy and/or drug. Would not a BP like Merck
which has Keytruda want to do some trials with Vazkepa? My hope is that Denner is working
on this.